Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03737123
Title Trial of Atezolizumab Plus Chemotherapy After Progression on Single Agent PD-1 or PD-L1 in Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nabil Adra
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
Nebraska Methodist Hosptial Omaha Nebraska 68114 United States Details
University of New Mexico Comprehensive Cancer Center Albuquerque New Mexico 87102 United States Details
University of Cincinnati Cancer Institute Cincinnati Ohio 45267 United States Details
*Shaded cells indicate that there was no data available from for the field